Skip to content

Nurse Sentenced to over 5 Years for Tampering with Fentanyl Intended for Patients

A Florida man was sentenced to five years and three months in federal prison for tampering with a consumer product and obtaining a controlled substance by fraud, the US Attorney’s Office for the Middle District of Florida announced on August 8, 2025.

According to court documents, the man was a Florida-licensed registered nurse who worked at several hospitals in the Tampa Bay area. He tampered with fentanyl intended for patients by removing a portion of the drug from its container—sometimes diluting it with another substance—and using it for his own personal use. In doing so, he acted with reckless disregard for the risk of death or serious injury to patients, under circumstances showing extreme indifference to that risk.

Between June 2 and September 12, 2023, the nurse committed multiple acts of theft. On seven occasions, he took needles, syringes, and saline flushes from the supply room, entered a treatment room where another nurse’s patient was receiving intravenous fentanyl, and stole the drug by redirecting it into a Styrofoam cup. At other times, he stole fentanyl directly from a secure medication locker or manipulated IV pumps to access the drug. He then injected himself in a hospital restroom.

His conduct came to light on September 12, 2023, when he volunteered to change a fentanyl IV drip bag for a patient, even though he was not assigned to care for that patient. He obtained a 100mL fentanyl IV bag and tubing from the secure medication locker and administered it. Shortly afterward, he was seen stumbling, slurring his speech, and falling asleep. Nurses found a bloody needle and a paper towel in the restroom, evidence of drug use. When asked to take a drug test, he refused and was subsequently terminated.

Lab testing later confirmed that the fentanyl IV bag he administered had been tampered with—approximately 50 percent of the drug had been removed and replaced with saline.

Compliance Perspective

Issue

Substance use disorders affect an estimated 17.1 percent of the US population. Healthcare workers, particularly nurses, may be at increased risk due to their routine access to controlled substances. In healthcare settings, the diversion of these substances by staff poses serious risks—including harm to patients, regulatory noncompliance, and potential legal consequences. Diversion may constitute abuse, neglect, misappropriation, or fraud under both state and federal regulations. Staff involved in diversion may use a variety of methods to conceal their actions, such as manipulating medication dispensing systems or entering patient treatment areas under false pretenses. It is critical that healthcare facilities implement robust diversion-prevention programs to identify high-risk medications, recognize behavioral and documentation red flags, and detect signs of staff impairment.

Discussion Points

  • Review and your facility’s policies and procedures for preventing, identifying, and responding to drug diversion. Ensure that they align with current federal and state regulations and reflect emerging methods of diversion. Facilities may benefit from working with experienced external consultants to evaluate policy effectiveness, provide regulatory insight, and support quality improvement initiatives.
  • Provide continuous training for relevant staff on identifying signs of substance misuse and drug diversion. Emphasize the serious consequences of diversion—including harm to patients—and reinforce that it is considered abuse and neglect. Clearly communicate staff responsibilities regarding timely reporting and the legal and professional consequences of diversion. Med-Net Academy (MNA) offers three PowerPoint training programs in the Substance Use category; visit MNA to access these resources.
  • Conduct regular audits to confirm accurate documentation and reconciliation of all controlled substances. Pay particular attention to shift logs, IV pump records, and medication access reports. Facilities may also consider engaging their pharmacy consultant or an external mock surveyor to conduct targeted reviews of high-risk practices or units. Objective reviews can help uncover patterns that internal teams may overlook and support early intervention efforts.

*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*